Evidence map›Paper›PMID 35367774›Full record

ArticleEBioMedicine2022

Telomere-length dependent T-cell clonal expansion: A model linking ageing to COVID-19 T-cell lymphopenia and mortality.

James J Anderson, Ezra Susser, Konstantin G Arbeev, Anatoliy I Yashin, Daniel Levy, Simon Verhulst, Abraham Aviv

Open access · goldAbstract read
In one paragraph

Article in EBioMedicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. PeerJ · 2023
    Article
  13. Review
  14. Article
  15. The bullwhip effect, T-cell telomeres, and SARS-CoV-2.The lancet. Healthy longevity · 2022
    Review
  16. Article
  17. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 2 countries.

James J AndersonSchool of Aquatic and Fishery Sciences, University of Washington, Seattle, WA 98195, USA. Electronic address: jjand@uw.edu.
Ezra SusserDepartment of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY 10032, USA; New York State Psychiatric Institute, New York, NY 10032, USA.
Konstantin G ArbeevBiodemography of Aging Research Unit, Social Science Research Institute, Duke University, Durham, NC 27705, USA.
Anatoliy I YashinBiodemography of Aging Research Unit, Social Science Research Institute, Duke University, Durham, NC 27705, USA.
Daniel LevyPopulation Sciences Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 27705, USA; The Framingham Heart Study, Framingham, MA 01702, USA.
Simon VerhulstGroningen Institute for Evolutionary Life Sciences, University of Groningen, Groningen, the Netherland.
Abraham AvivThe Center of Human Development and Aging, New Jersey Medical School, Rutgers University, Newark, NJ 07103, USA.
Social Science Research Council · USNational Institutes of Health · USNew York Psychoanalytic Society and Institute · USRutgers, The State University of New Jersey · USUniversity of Groningen · NLUniversity of Washington · US

Funding

Scientific/Technical CoreP2CHD042828 · NICHD · UNIVERSITY OF WASHINGTON · PI SARA R. CURRAN · 2017 to 2026
$6.3M
Genetics of changes in population pyramids: Implications for health forecasting with a focus on Alzheimer's Disease and related dementiasRF1AG046860 · NIA · DUKE UNIVERSITY · PI YASHIN, ANATOLIY I · 2019 to 2019
$3.1M
Elucidating the measurement of telomeres: Development of a transdisciplinary, high-impact Telomere Research NetworkU24AG066528 · NIA · TULANE UNIVERSITY OF LOUISIANA · PI DRURY, STACY SCHMIDT · 2019 to 2023
$3.0M
Telomere Length Measurements: Strengths and LimitationsU01AG066529 · NIA · RBHS-NEW JERSEY MEDICAL SCHOOL · PI AVIV, ABRAHAM · 2019 to 2021
$911k
Shorter T-cell telomeres, lymphopenia, and high mortality of older people with COVID-19R56AG073226 · NIA · RBHS-NEW JERSEY MEDICAL SCHOOL · PI AVIV, ABRAHAM, KRAFT, BRYAN D. · 2021 to 2021
$322k
NIA NIH HHS R56 AG073226NIA NIH HHS RF1 AG046860NIA NIH HHS U01 AG066529NIA NIH HHS U24 AG066528NICHD NIH HHS P2C HD042828
6 · The paper itself

Abstract

backgroundSevere COVID-19 T-cell lymphopenia is more common among older adults and entails poor prognosis. Offsetting the decline in T-cell count during COVID-19 demands fast and massive T-cell clonal expansion, which is telomere length (TL)-dependent.

methodsWe developed a model of TL-dependent T-cell clonal expansion capacity with age and virtually examined the relation of T-cell clonal expansion with COVID-19 mortality in the general population.

findingsThe model shows that an individual with average hematopoietic cell TL (HCTL) at age twenty years maintains maximal T-cell clonal expansion capacity until the 6th decade of life when this capacity rapidly declines by more than 90% over the next ten years. The collapse in the T-cell clonal expansion capacity coincides with the steep increase in COVID-19 mortality with age.

interpretationShort HCTL might increase vulnerability of many older adults, and some younger individuals with inherently short HCTL, to COVID-19 T-cell lymphopenia and severe disease.

fundingA full list of funding bodies that contributed to this study can be found in the Acknowledgements section.

Indexed as

COVID-19LymphopeniaAdultAgedAgingHumansTelomereT-LymphocytesYoung AdultAgeingCOVID-19SARS-CoV-2T-cellsTelomeresVaccines

Identifiers

PMID35367774
PMCPMC8970968
OpenAlexW4220729213

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.